BioInformant

Your Global Leader in Stem Cell Market Research

MENUMENU
  • Blog
    • Interviews
  • News
  • Stem Cells
    • iPS Cells
    • MSCs
    • HSCs
    • Adipose SCs
    • Neural Stem Cells
  • Exosomes
  • CAR-T
  • Cord Blood
  • Shop
    • Products
    • Submit PR
    • Advertise
  • About
    • Testimonials
    • Story
    • Guarantee
    • Contact
  • Home
  • Blog
    • Stem Cells
      • HSCs
      • iPS Cells
      • MSCs
      • Neural Stem Cells
      • Adipose SCs
    • Exosomes
    • Cell Therapy
      • CAR-T
    • Cord Blood
    • Stem Cell News
    • Interviews
  • COVID-19
  • Shop
  • Submit PR
  • Company
    • Advertise
    • Testimonials
    • Story
    • Job Posts
    • Guarantee
    • Privacy Policy
    • Contact
Home » 3 Bullet Thursday | Stem Cells (Sept 24, 2015)
3 Bullet Thursday | Stem Cells (Sept 24, 2015)

3 Bullet Thursday | Stem Cells (Sept 24, 2015)

September 24, 2015 By Cade Hildreth (CEO) Leave a Comment

Stay alert to the latest and greatest on stem cells.  Enjoy this week’s “3 Bullet Thursday,” a weekly post that we do to update you on interesting and important findings within the world of stem cells.

Discover class-defining bioproduction tools.

iPSC July News Round Up1) These three countries deserve a mention for their recent stem cell innovation:

  • Japan approved its first ever allogeneic stem cell product.
  • Canada made headlines after a cord blood donation became the first stem cell transplant among siblings from a public cord blood bank.
  • Britain’s embryology regulator received an application to genetically modify an embryo, which would be the first since a Chinese attempt earlier this year.


Bioprinting of Pill2) In other breaking news, the U.S. FDA gave the go ahead for the world’s first ever 3D printed pill. The technology that will allow precise, patient-by-patient dosing and on-site production of medications.

Totally incredible.

Rooster DevServices

Of course, progress with 3D printing of stem cells is also advancing with leaps and bounds.


8 Companies Competing in the Dental Stem Cell Storage Market3) This article on dental stem cell storage has gotten the most views of any article on our site over the past week, suggesting growing interest in this “up and coming” stem cell market segment.

bitbio
*Note: Back in the early 2000’s, cord blood banking caught our attention in the same way, with little indicators suggesting that the market could take off. Now there are almost 500 cord blood banks worldwide. While it’s too early to tell, we will keep an eye on this emerging market segment. Stay tuned…

Want to get this fun weekly update?  Join below and we’ll keep you in the loop, starting next week!

Pluristyx
Rate this post

Filed Under: Stem Cells Tagged With: 3 bullet thursday, cord blood, market news, stem cells, updates, weekly update

Related

About Cade Hildreth (CEO)

Cade Hildreth is the Founder of BioInformant.com, the world's largest publisher of stem cell industry news. Cade is a media expert on stem cells, recently interviewed by the Wall Street Journal, Los Angeles Business Journal, Xconomy, and Vogue Magazine. 

Tell Us What You Think! Cancel reply

Nanocellect

Marathon Products

Kimera Society

Let’s Get Social

  • Facebook
  • Twitter
  • LinkedIn
  • Pinterest
  • Instagram

Cart

Featured Posts

clean meat market

Clean Meat Market: Stem Cell Derived “Clean Meat” Attracts Billionaires

what are exosomes | definition

What are Exosomes, Exactly?

Who discovered stem cells?

Who Discovered Stem Cells? The Answers Revealed

My Tweets

BioInformant's World-Class Clients

  • Submit Press Release
  • Advertise
  • Privacy and Terms

Copyright © 2022 · BIOINFORMANT, Your Global Leader in Stem Cell Market Research

| Email: [email protected] | Phone: 703-859-7617 |

800 Corporate Drive, Suite 301, Stafford, VA 22554, United States

Disclaimer: All statements made on this website are NOT expressed as medical claims or advice. They are not intended to diagnose, treat, cure or prevent any disease or condition. If you have a health condition or concern, consult your physician or health care provider.